AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Trial: 20460999
Drug: Ropivacaine doses
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ropivacaine doses
Trial: 16378790
Drug: Combination of
RxNorm normalized name: combination of rauwolfia alkaloids and diuretics incl. other combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination of electronic and direct detailing
Trial: 9527978
Drug: OMC (omeprazole
FDA approved: no
EMA approved: no
PMDA approved: no
Description: OMC (omeprazole 20 mg b.i.d., metronidazole 500 mg b.i.d., clarithromycin 500 mg b.i.d.)
Trial: 9527978
Drug: OMA (omeprazole
FDA approved: no
EMA approved: no
PMDA approved: no
Description: OMA (omeprazole 20 mg b.i.d., metronidazole 500 mg b.i.d., amoxycillin 1 g b.i.d.)
Trial: 911706
Drug: Iron+folate supplements
RxNorm normalized name: folate
DrugBank: Folic acid (DB00158)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Iron+folate supplements
Trial: 23929659
Drug: Darexaban 20
RxNorm normalized name: Darexaban
DrugBank: Darexaban (DB12289)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Darexaban 20 mg
Trial: 23929659
Drug: Darexaban 120
RxNorm normalized name: Darexaban
DrugBank: Darexaban (DB12289)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Darexaban 120 mg
Trial: 23929659
Drug: Darexaban 240
RxNorm normalized name: Darexaban
DrugBank: Darexaban (DB12289)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Darexaban 240 mg
Trial: 19631122
Drug: Stromal hydration
RxNorm normalized name: Chloral Hydrate
DrugBank: Chloral hydrate (DB01563)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Stromal hydration with balanced salt solution
Trial: 10982755
Drug: 5 mg
RxNorm normalized name: talc 25 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 5 mg risedronate (n = 255)
Trial: 10982755
Drug: 10 mg
RxNorm normalized name: biotin 10 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 10 mg alendronate (n = 260)
Trial: 27799644
Drug: CHoBI7 intervention
RxNorm normalized name: hydroquinone
DrugBank: Hydroquinone (DB09526)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: CHoBI7 intervention (handwashing with soap and water treatment during hospital stay and home visits)
Trial: 17380213
Drug: Amlodipine besylate
RxNorm normalized name: Amlodipine Besylate
DrugBank: Amlodipine (DB00381)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Amlodipine besylate and atorvastatin calcium single-pill combination (5 or 10 mg amlodipine and 10 mg atorvastatin)
Trial: 17380213
Drug: Amlodipine besylate
RxNorm normalized name: Amlodipine Besylate
DrugBank: Amlodipine (DB00381)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Amlodipine besylate and atorvastatin calcium single-pill combination
Trial: 10233185
Drug: Cisapride 20
RxNorm normalized name: cisapride 20 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cisapride 20 mg b.d. orally
Trial: 8966140
Drug: Intravenous 25%
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intravenous 25% magnesium sulphate infusion (20 ml dissolved in 500 ml 5% dextrose for 60 minutes)
Trial: 28599949
Drug: Quetiapine-ER (600
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Quetiapine-ER (600 mg/day)
Trial: 28599949
Drug: Aripiprazole (20
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Aripiprazole (20 mg/day)
Trial: 20632462
Drug: Oral estradiol
RxNorm normalized name: estradiol Oral Tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral estradiol therapy (ET)
Trial: 21366801
Drug: Combined hepatitis
RxNorm normalized name: hepatitis nosodes
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combined hepatitis A/B vaccine
Trial: 10706965
Drug: Monovalent hepatitis
RxNorm normalized name: hepatitis nosodes
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Monovalent hepatitis B vaccine
Trial: 3754834
Drug: Defibrotide (800
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Defibrotide (800 mg daily, 200 mg intravenously 4 times a day for 7 days)
Trial: 2450026
Drug: sotalol 160
RxNorm normalized name: sotalol 160 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: sotalol 160 mg b.d.
Trial: 2450026
Drug: atenolol 50
RxNorm normalized name: atenolol 50 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: atenolol 50 mg b.d.
Trial: 31033008
Drug: Preoperative Extracorporeal
RxNorm normalized name: ethanol
DrugBank: Ethanol (DB00898)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Preoperative Extracorporeal Shockwave Therapy (ESWT)
Trial: 29909374
Drug: Cognitive Behavior
RxNorm normalized name: Mahana Parallel Digital Cognitive Behavioral Therapy Mobile Application for Irritable Bowel Syndrome
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cognitive Behavior Therapy for Command Hallucinations (CTCH)
Trial: 24346114
Drug: Dexamphetamine (0.45
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dexamphetamine (0.45 mg/kg, per os)
Trial: 9078541
Drug: Glutamine (0.2
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Glutamine (0.2 g.kg‐1.d‐1 on the day of the study) supplemented formula
Trial: 8104348
Drug: 15 mg
RxNorm normalized name: papain 15 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 15 mg haloperidol i.v. for 3 days followed by 3 x 5 mg haloperidol p.o./d
Trial: 8104348
Drug: 3 x
RxNorm normalized name: Xenon (133 xe)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 3 x 100 mg perazin p.o./d
Trial: 3743144
Drug: Placebo bronchodilator
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo bronchodilator
Trial: 3743144
Drug: Inhaled fenoterol
RxNorm normalized name: fenoterol
DrugBank: Fenoterol (DB01288)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Inhaled fenoterol and placebo
Trial: 26125285
Drug: Fixed combination
RxNorm normalized name: Progestogens and estrogens, fixed combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fixed combination of soy isoflavones (60 mg) administered concomitantly with levothyroxine
Trial: 26125285
Drug: Levothyroxine administered
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Levothyroxine administered 6 hours after soy isoflavones
Trial: 23147689
Drug: Beta-blockers (BB)
RxNorm normalized name: Beta Carotene
DrugBank: Beta carotene (DB06755)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Beta-blockers (BB) therapy for 12 weeks
Trial: 18575771
Drug: Topical sucralfate
RxNorm normalized name: Sucralfate
DrugBank: Sucralfate (DB00364)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Topical sucralfate (SUC‐LIS 95) applied daily for a median period of 42.0 days
Trial: 18575771
Drug: Topical sucralfate
RxNorm normalized name: Sucralfate
DrugBank: Sucralfate (DB00364)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Topical sucralfate (SUC‐LIS 95)
Trial: 11409190
Drug: Fluoxetine drops
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fluoxetine drops
Trial: 11409190
Drug: Marketed fluoxetine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Marketed fluoxetine capsules
Trial: 8210919
Drug: etodolac SR
RxNorm normalized name: Etodolac
DrugBank: Etodolac (DB00749)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: etodolac SR 400 mg once daily (q.d.)
Trial: 8210919
Drug: etodolac SR
RxNorm normalized name: Etodolac
DrugBank: Etodolac (DB00749)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: etodolac SR 600 mg once daily (q.d.)
Trial: 8210919
Drug: etodolac 200
RxNorm normalized name: etodolac 200 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: etodolac 200 mg twice daily (b.i.d.)
Trial: 8210919
Drug: etodolac 300
RxNorm normalized name: etodolac 300 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: etodolac 300 mg twice daily (b.i.d.)
Trial: 3513715
Drug: Oral prednisolone
RxNorm normalized name: prednisolone Oral Solution
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral prednisolone 2 mg/kg/day in two divided doses for five days
Trial: 28301043
Drug: Topical Treatment
RxNorm normalized name: Topicale
DrugBank: Benzocaine (DB01086)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Topical Treatment Optimization Programme (TTOP)
Trial: 23784346
Drug: Valproic acid
RxNorm normalized name: Valproic Acid
DrugBank: Valproic acid (DB00313)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Valproic acid (VPA) 500 mg oral single dose
Trial: 21690118
Drug: Family-based behavioral
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Family-based behavioral weight loss treatment (FBT)
Trial: 19559476
Drug: Eflornithine (400
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Eflornithine (400 mg/kg per day, every 6 h) for 14 days
Trial: 19559476
Drug: Nifurtimox-eflornithine combination
RxNorm normalized name: nifurtimox
DrugBank: Nifurtimox (DB11820)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Nifurtimox-eflornithine combination therapy (NECT): Eflornithine (400 mg/kg per day, every 12 h) for 7 days with oral Nifurtimox (15 mg/kg per day, every 8 h) for 10 days
Trial: 11063062
Drug: In-depth computerized
RxNorm normalized name: Immunoglobulin G4, anti-programmed cell death protein 1 (PDCD1) (humanized clone ABT1 gamma4-chain), disulfide with humanized clone ABT1 kappa-chain, dimer
FDA approved: no
EMA approved: no
PMDA approved: no
Description: In-depth computerized assessment administered by an interviewer
Trial: 11063062
Drug: Self-administered audio-computer
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Self-administered audio-computer assisted interview
Trial: 9284898
Drug: L-arginine (0.5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: L-arginine (0.5 g/min in the last 60 minutes of the clamp)
Trial: 9284898
Drug: D-arginine (0.5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: D-arginine (0.5 g/min in the last 60 minutes of the clamp)
Trial: 7951278
Drug: Analgesic 1
RxNorm normalized name: CVS Hemorrhoidal & Analgesic 1% Topical Ointment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Analgesic 1 at two dosage levels
Trial: 7951278
Drug: Analgesic 2
RxNorm normalized name: Leader Oral Analgesic 20% Maximum Strength Topical Gel
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Analgesic 2 at two dosage levels
Trial: 3300436
Drug: Nebulized bitolterol
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nebulized bitolterol solution, 2.5 mg three times a day for 1 month
Trial: 3300436
Drug: Nebulized isoproterenol
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nebulized isoproterenol solution, 2.5 mg three times a day for 1 month
Trial: 30273922
Drug: Quadriceps strengthening
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Quadriceps strengthening program (3 times weekly)
Trial: 25677679
Drug: QVA149 110/50
FDA approved: no
EMA approved: no
PMDA approved: no
Description: QVA149 110/50 µg once daily
Trial: 25677679
Drug: TIO 18
FDA approved: no
EMA approved: no
PMDA approved: no
Description: TIO 18 µg once daily + FOR 12 µg twice daily
Trial: 23305631
Drug: Tocilizumab 8
RxNorm normalized name: tocilizumab 80 MG in 4 ML Injection
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Tocilizumab 8 mg/kg plus DMARDs
Trial: 18343646
Drug: Salmeterol/fluticasone combination
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Salmeterol/fluticasone combination (SFC) 50/250 microg
Trial: 14633181
Drug: Induction treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Induction treatment with interferon alpha 2b 5 million units (MU) subcutaneously (s.c.) daily for 8 weeks
Trial: 14633181
Drug: Standard treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Standard treatment with interferon alpha 2b 5 MU s.c. three times a week (TIW) for 8 weeks
Trial: 14633181
Drug: Both arms
RxNorm normalized name: Bothrops atrox venom
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Both arms received ribavirin (1000-1200 mg orally per day) starting at week 4
Trial: 9154538
Drug: Original formulation
RxNorm normalized name: Zegerid (Original Formulation)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Original formulation of amoxicillin/clavulanate potassium (Augmentin) administered tid for 10 days (40/10 mg/kg/day)
Trial: 9154538
Drug: New formulation
RxNorm normalized name: TRIPROLIDINE HYDROCHLORIDE 1.25 mg in 1 mL ORAL SYRUP [HISTEX PD Drops New Formulation]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: New formulation of amoxicillin/clavulanate potassium (Augmentin) administered bid for 10 days (45/6.4 mg/kg/day)
Trial: 9154538
Drug: New formulation
RxNorm normalized name: TRIPROLIDINE HYDROCHLORIDE 1.25 mg in 1 mL ORAL SYRUP [HISTEX PD Drops New Formulation]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: New formulation of amoxicillin/clavulanate potassium (Augmentin) administered bid for 5 days (45/6.4 mg/kg/day)
Trial: 2670309
Drug: Plain tablets
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Plain tablets of pyronaridine (0.5 g on day 1, 0.3 g on day 2)
Trial: 2670309
Drug: Enteric-coated tablets
RxNorm normalized name: lipase
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Enteric-coated tablets of pyronaridine (0.4 g x 2 on day 1, 0.4 g on day 2)
Trial: 779663
Drug: Loperamide 2
RxNorm normalized name: loperamide 2 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Loperamide 2 mg capsules
Trial: 28324167
Drug: Golimumab 100
RxNorm normalized name: golimumab 100 MG/ML
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Golimumab 100 mg subcutaneous injection every 4 weeks
Trial: 22149065
Drug: Vitamin D3
RxNorm normalized name: Vitamin D3
DrugBank: Cholecalciferol (DB00169)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Vitamin D3 (800 IU) and Calcium (2 g)
Trial: 18495735
Drug: Infliximab 5
RxNorm normalized name: Infliximab
DrugBank: Infliximab (DB00065)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: Infliximab 5 mg/kg every 6 weeks through week 96
Trial: 18495735
Drug: Infliximab 7.5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Infliximab 7.5 mg/kg (after dose escalation starting at week 36)
Trial: 8944402
Drug: alprazolam (0.5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: alprazolam (0.5 and 1 mg)
Trial: 21603892
Drug: alprazolam (1
FDA approved: no
EMA approved: no
PMDA approved: no
Description: alprazolam (1 mg)
Trial: 8944402
Drug: alprazolam (1
FDA approved: no
EMA approved: no
PMDA approved: no
Description: alprazolam (1 mg) and lorazepam (2 mg)
Trial: 1956688
Drug: sulphate quinine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: sulphate quinine (30 mg/kg bw/day in three divided doses)
Trial: 1956688
Drug: fansidar (sulphadoxine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: fansidar (sulphadoxine 20-30 mg/kg bw/day, single dose)
Trial: 6111670
Drug: Cefazolin (5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cefazolin (5 days of antibiotic prophylaxis, starting just before surgery)
Trial: 30676542
Drug: Transdermal fentanyl
RxNorm normalized name: fentanyl Transdermal System
DrugBank: Fentanyl (DB00813)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Transdermal fentanyl patch (TFP) 25 μg/h applied 14 hours before operation
Trial: 30676542
Drug: Intravenous continuous
RxNorm normalized name: Ivy Dry Super Continuous Spray
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intravenous continuous fentanyl (25 μg/h) with loading dose (25 μg) in control group
Trial: 25958101
Drug: Fibrinolytic group
RxNorm normalized name: Streptococcus viridans group
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fibrinolytic group (streptokinase 250,000 IU in 50 ml saline)
Trial: 25958101
Drug: Control group
RxNorm normalized name: meningococcal group B vaccine Prefilled Syringe [Trumenba]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control group (50 ml saline)
Trial: 23648056
Drug: High-dose ropivacaine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High-dose ropivacaine (3mg/kg)
Trial: 23648056
Drug: Low-dose ropivacaine
RxNorm normalized name: ethinyl estradiol
DrugBank: Ethinylestradiol (DB00977)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Low-dose ropivacaine (1.5mg/kg)
Trial: 16283925
Drug: Bright white
RxNorm normalized name: PROPOLIS EXTRACT 7 g in 140 g / MENTHA PIPERITA (PEPPERMINT) STEM EXTRACT 1.4 g in 140 g / CHRYSANTHELLUM INDICUM FLOWER OIL 1.4 g in 140 g ORAL PASTE [BARUBT Probiotics Bright White Tooth-Paste]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Bright white light treatment (8,500 Lux) for one hour a day
Trial: 16283925
Drug: Dim red
RxNorm normalized name: acid red 35
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dim red light treatment (<10 Lux) for one hour a day
Trial: 16283925
Drug: Placebo (dim
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo (dim red light treatment)
Trial: 12817911
Drug: Recombinant human
RxNorm normalized name: Recombinant human TNF
DrugBank: Etanercept (DB00005)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: Recombinant human erythropoietin (r‐HuEpo) treatment
Trial: 8904622
Drug: Minaprine 100
RxNorm normalized name: minaprine 100 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Minaprine 100 mg once daily
Trial: 8904622
Drug: Minaprine 200
RxNorm normalized name: minaprine
DrugBank: Minaprine (DB00805)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Minaprine 200 mg once daily
Trial: 8904622
Drug: Minaprine 300
RxNorm normalized name: minaprine
DrugBank: Minaprine (DB00805)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Minaprine 300 mg once daily
Trial: 8904622
Drug: Amitriptyline 150
RxNorm normalized name: amitriptyline 150 mg oral tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Amitriptyline 150 mg once daily (75 mg during the first week)
Trial: 31340956
Drug: Integrated GP
RxNorm normalized name: carbetapentane citrate / guaifenesin Oral Solution [Pulmari-GP]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Integrated GP care plus treatment as usual (includes GP training in cognitive behavioural skills, GP supervision, and written/audio-visual materials for GPs and participants)
Trial: 27223813
Drug: Oral vinorelbine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral vinorelbine plus cisplatin
Trial: 18536386
Drug: Xianglingwan administered
RxNorm normalized name: no vaccine administered
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Xianglingwan administered from the fifth day of the menstrual cycle for 3 weeks every month for three months
Trial: 10875786
Drug: Tuberculosis vaccine
RxNorm normalized name: Tuberculosis vaccines
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Tuberculosis vaccine (exact details not specified)
Trial: 6653131
Drug: Combination of
RxNorm normalized name: combination of rauwolfia alkaloids and diuretics incl. other combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination of orphenadrine (35 mg) and paracetamol (450 mg) tablets, 1 tablet 3 times daily
Trial: 30340939
Drug: Transdermal oestrogen
RxNorm normalized name: estrogens
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Transdermal oestrogen (oestradiol hemihydrate patches)
Trial: 30340939
Drug: Oral oestrogen
RxNorm normalized name: estrogens
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral oestrogen (oestradiol valerate pills)
Trial: 26903143
Drug: Home-based robot-guided
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Home-based robot-guided therapy
Trial: 26903143
Drug: Laboratory-based robot-guided
RxNorm normalized name: lidocaine
DrugBank: Lidocaine (DB00281)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Laboratory-based robot-guided therapy
Trial: 9448170
Drug: Omeprazole 40
RxNorm normalized name: omeprazole 40 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Omeprazole 40 mg b.i.d., clarithromycin 500 mg b.i.d., colloidal bismuth subcitrate 120 mg q.i.d. for 7 days
Trial: 9448170
Drug: Omeprazole 40
RxNorm normalized name: omeprazole 40 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Omeprazole 40 mg b.i.d., clarithromycin 500 mg b.i.d., amoxicillin 1 g b.i.d. for 7 days
Trial: 31419353
Drug: Active treatment
RxNorm normalized name: Activated Charcoal
DrugBank: Activated charcoal (DB09278)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Active treatment group (ATG, n = 13)
Trial: 31419353
Drug: Passive treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Passive treatment group (PTG, n = 13)
Trial: 30635159
Drug: SBC-103 (5.0
FDA approved: no
EMA approved: no
PMDA approved: no
Description: SBC-103 (5.0 mg/kg)
Trial: 30635159
Drug: SBC-103 (10.0
FDA approved: no
EMA approved: no
PMDA approved: no
Description: SBC-103 (10.0 mg/kg)
Trial: 23640009
Drug: Nicotine patch
RxNorm normalized name: Nicotine Patch
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nicotine patch alone (control condition)
Trial: 23640009
Drug: Bupropion augmentation
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Bupropion augmentation of the patch
Trial: 21832964
Drug: Oral sea
RxNorm normalized name: Deep Sea
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral sea buckthorn oil (2 g daily for 3 months)
Trial: 21832964
Drug: Placebo oil
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo oil (2 g daily for 3 months)
Trial: 16989377
Drug: Amoxicillin added
RxNorm normalized name: Amoxicillin
DrugBank: Amoxicillin (DB01060)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Amoxicillin added to treatment
Trial: 16989377
Drug: Hearing test
RxNorm normalized name: mumps skin test antigen
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Hearing test before and after treatment
Trial: 3485757
Drug: Atenolol (100
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Atenolol (100 mg X d‐1)
Trial: 3485757
Drug: Propranolol (160
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Propranolol (160 mg X d‐1)
Trial: 31410672
Drug: SRP with
RxNorm normalized name: Primatene with ephedrine Pill
FDA approved: no
EMA approved: no
PMDA approved: no
Description: SRP with photodynamic therapy (670 nm)
Trial: 22752384
Drug: GSK1521498 5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: GSK1521498 5 mg/day
Trial: 20220282
Drug: Music therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Music therapy (40 min, once a day for 8 days)
Trial: 11390728
Drug: Vitamin C
RxNorm normalized name: Vitamin C
DrugBank: Sodium ascorbate (DB14482)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Vitamin C (2 g oral administration)
Trial: 9232130
Drug: Intravenous phenylephrine,
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intravenous phenylephrine, 50‐200 micrograms/min, titrated to a 20% increase in mean arterial blood pressure
Trial: 9232130
Drug: Inhaled nitric
RxNorm normalized name: nitric oxide Inhalant Product
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Inhaled nitric oxide (NO), 40 ppm